The clinical features observed in our two Rwandan siblings, including early-onset spasticity, motor developmental delay, intellectual disability, and seizures, are consistent with previous reports of SPG52 caused by AP4S1 mutations. This evidence concerns the gene AP4S1 and Global developmental delay.